Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
The EURODIAB IDDM Complications Study involved the examination of 3250 randomly selected insulin-dependent diabetic patients, from 31 centres in 16 European countries. Part of the examination included an assessment of neurological function including neuropathic symptoms and physical signs, vibration perception threshold, tests of autonomic function and the prevalence of impotence. The prevalence of diabetic neuropathy across Europe was 28% with no significant geographical differences. Significant correlations were observed between the presence of diabetic peripheral neuropathy with age (p < 0.05), duration of diabetes (p < 0.001), quality of metabolic control (p < 0.001), height (p < 0.01), the presence of background or proliferative diabetic retinopathy (p < 0.01), cigarette smoking (p < 0.001), high-density lipoprotein cholesterol (p < 0.001) and the presence of cardiovascular disease (p < 0.05), thus confirming previous associations. New associations have been identified from this study - namely with elevated diastolic blood pressure (p < 0.05), the presence of severe ketoacidosis (p < 0.001), an increase in the levels of fasting triglyceride (p < 0.001), and the presence of microalbuminuria (p < 0.01). All the data were adjusted for age, duration of diabetes and HbA1c. Although alcohol intake correlated with absence of leg reflexes and autonomic dysfunction, there was no overall association of alcohol consumption and neuropathy. The reported problems of impotence were extremely variable between centres, suggesting many cultural and attitudinal differences in the collection of such information in different European countries. In conclusion, this study has identified previously known and new potential risk factors for the development of diabetic peripheral neuropathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Furthermore, even in more contemporary cohorts with recent-onset T2D prevalence rates of up to 25% have been observed,545,546 including in youth417,612–615 or at different degrees of glucose intolerance.616”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [545]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Young, M. J., Boulton, A. J. M., Macleod, A. F., Williams, D. R. R., & Sonksen, P. H. (1993) · Diabetologia · doi:10.1007/bf00400697 · Cited by 1,502
Dyck, P. J., Kratz, K. M., Karnes, J. L., Litchy, W. J., Klein, R., Pach, J. M., Wilson, D. M., O'Brien, P. C., & Melton, L. J. (1993) · Neurology · doi:10.1212/wnl.43.4.817 · Cited by 1,482
The Value of Cardiovascular Autonomic Function Tests: 10 Years Experience in Diabetes
Ewing, D. J., Martyn, C. N., Young, R. J., & Clarke, B. F. (1985) · Diabetes Care · doi:10.2337/diacare.8.5.491 · Cited by 1,434 · cited 1×
“1) the presence of one or more symptoms; 2) absence of two or more ankle or knee reflexes; 3) vibration perception threshold which was abnormal relating to age-related measures [12] and 4) abnormal autonomic function assessed using Ewing’s definitons [13] of postural hypotension with a fall in systolic blood pressure…”
MethodPirart, J. (1978) · Diabetes Care · doi:10.2337/diacare.1.3.168 · Cited by 1,290
Maser, R. E., Steenkiste, A. R., Dorman, J. S., Nielsen, V. K., Bass, E. B., Manjoo, Q., Drash, A. L., Becker, D. J., Kuller, L. H., Greene, D. A., et al. (1989) · Diabetes · doi:10.2337/diab.38.11.1456 · Cited by 408
Pirart, J. (1978) · Diabetes Care · doi:10.2337/diacare.1.4.252 · Cited by 358
Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study
Stephenson, J., Fuller, J. H., & EUROBIAB IDDM Complications Study Group (1994) · Diabetologia · doi:10.1007/bf00398055 · Cited by 345
Self-citationReport and Recommendations of the San Antonio Conference on Diabetic Neuropathy
(1988) · Diabetes · doi:10.2337/diab.37.7.1000 · Cited by 308
Malik, R. A., Newrick, P. G., Sharma, A. K., Jennings, A., Ah-See, A. K., Mayhew, T. M., Jakubowski, J., Boulton, A. J. M., & Ward, J. D. (1989) · Diabetologia · doi:10.1007/bf00505180 · Cited by 294
Self-citationSENSORY NEUROPATHY IN NON-INSULIN-DEPENDENT DIABETES MELLITUS
FRANKLIN, G. M., KAHN, L. B., BAXTER, J., MARSHALL, J. A., & HAMMAN, R. F. (1990) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115547 · Cited by 281
Cited by
Items 601–693 of 693
Editor's Selection: This Month's Highlighted Articles
Hitman, G. A. (2013) · Diabetic Medicine · doi:10.1111/dme.12281
Spinal Cord Stimulation in the Treatment of Postherpetic Neuralgia
Golovac, S., & Raso, L. J. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1824-9_49
PULSE WAVE ANALYSIS IN TYPE 1 DIABETES: RELATIONSHIP WITH HISTORICAL MEASURES AND PREVALENT DISEASE
Prince, C. T. (2008) · D-Scholarship@Pitt (University of Pittsburgh)
Long term complications in juvenile diabetes mellitus
Nordwall, M. (2006) · DiVA (Linkoping University)
Thomas, J., Stewart, D. W., Daley, C. M., Befort, C. A., James, A. S., Snow, P. M., Scherber, R. M., & Ahluwalia, J. S. (2009) · Kansas Journal of Medicine · doi:10.17161/kjm.v2i2.11288
“College degree 6 ( 24 ) 8 (32) 1 (4) 9 (36) 1 (4)”
Peripheral Nerve Decline Impacts Lower Extremity Muscle Function in Older Adults
Ward, R. E. (2013) · D-Scholarship@Pitt (University of Pittsburgh)
Severe Hypoglycemic Attacks in Type 1 Diabetes From the EURODIAB IDDM Complications Study
Gruden, G., Giunti, S., Barutta, F., Chaturvedi, N., Witte, D. R., Tricarico, M., Fuller, J., Perin, P. C., & Bruno, G. (2012)
Self-citationSchmerzhafte diabetische Neuropathie
Jecht, M. (2011) · Der Diabetologe · doi:10.1007/s11428-011-0803-z
STUDY OF DIABETES PATIENTS WITH PERIPHERAL NEUROPATHY IN BRIMS TEACHING HOSPITAL, BIDAR
A, V. K. B., Patil, P., Mudbi, S., Kulkarni, S., Patil, S. B., & Uppar, T. (2014) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/2014/3182
Vascular Changes and Diabetic Neuropathy
Malik, R. A., Tesfaye, S. H., & Ward, J. D. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-091-9_23
Self-citationПоиск патогенетической терапии диабетической дистальной симметричной полинейропатии
(2015) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.17650/2222-8721-2013-0-3-8-15
Kent, D. L., & Campochiaro, P. A. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-310-1_22
Diabetes and Lower-Extremity Diseases
Boulton, A. J. M., & Bowling, F. L. (2010) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195317060.003.0008
Kida, Y., 大井二郎, Kashiwagi, A., & Kikkawa, R. (2002) · The Journal of Japan Atherosclerosis Society · doi:10.5551/jat1973.29.3_41
Neuropathies chez les diabétiques
Lozeron, P. (2016) · Encyclopédie médico-chirurgicale. Neurologie · doi:10.1016/s0246-0378(16)75572-2 · Cited by 1
NERVE CONDUC TION PROFILE IN TYPE II DIABETICS
Balaji, R., Mayilanandhi, K., Subashini, S., & Rajasekaran, D. (2015) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/2015/493
Diabetic neuropathy: Summary of treatment options
Chirayath, H. H. (2017) · Vascular Diseases and Therapeutics · doi:10.15761/vdt.1000116
“The Eurodiab Insulin-Dependent Diabetes Mellitus study found that suboptimal glycemic control was associated with the development of diabetic peripheral neuropathy in a large cohort of more than 3,000 people with Type 1 Diabetes [3].”
BackgroundA study to assess the efficacy of metabolic control of diabetes in the development of neuropathy
Ali, M. M., & Kumar, E. A. (2017) · International Journal of Advances in Medicine · doi:10.18203/2349-3933.ijam20173231
“Tesfaye S et al showed a significant correlation between diabetic neuropathy, age; duration of diabetes, diabetic retinopathy, cigarette smoking and prevalence of cardiovascular disease in IDDM patient.(1,2,12) This fact was brought out in this study.”
BackgroundDiabetisches Fußsyndrom im Alter
Eckert, S. (2017)
Cho, H. (2011) · Journal of the Korean Society for Research on Nicotine and Tobacco · doi:10.25055/jksrnt.2011.2.1.1
RISK FACTORS FOR EARLY DEVELOPMENT OF POLYNEUROPATHY AMONG TYPE II DIABETIC PATIENTS.
MahfouzH, M., HashemA, H., & Mostafa, Y. (2017) · International Journal of Advanced Research · doi:10.21474/ijar01/5416
CLINICAL AND ELECTROPHYSIOLOGICAL EVALUATION OF PATIENTS WITH DIABETIC NEUROPATHY
Kannan, V. (2009) · IJAR - Indian Journal of Applied Research
Glycemic Targets and Prevention of Chronic Complications
Cernea, S., Cahn, A., & Raz, I. (2018) · Endocrinology · doi:10.1007/978-3-319-27317-4_14-1
Anand, K. S., ., R., & Acharya, A. (2019) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20192503
“There are very few studies in India about the prevalence of microvascular complications and metabolic syndrome in low socio-economic group population particularly in early stages of type 2 diabetes.(3) There is lacuna of knowledge about the disease characteristics in this target group.”
BackgroundVitamin B12 and Holotranscobalamin Levels in Diabetic Peripheral Neuropathy Patients
Mohammed, N., Madhavi, K., Chandran, P. A., & Jabeen, S. A. (2016) · Indian Journal of Medical Biochemistry · doi:10.5005/jp-journals-10054-0004
Diabetic foot syndrome in elderly patients
Eckert, S. (2017) · Phlebologie · doi:10.12687/phleb2368-4-2017
“Up to 30 % also presented diabetic polyneuropathy (9).”
BackgroundKörei, A. E., Putz, Z., Vági, O. E., Istenes, I., Hajdú, N., & Kempler, P. (2017) · Diabetologia Hungarica · doi:10.24121/dh.2017.20
“A perifériás neuropathia és a kardiovaszkuláris kockázati tényezők közötti összefüggés a EURODIAB Complications Study óta bizonyított.(10) A vérnyomás- és lipidparaméterek rendezése, a trombocitaaggregáció-gátló kezelés egyben a makrovaszkuláris szövődmények megelőzésének is fontos eszköze, az obliteratív verőérbetegs…”
Boulton, A. J. M., & Malik, R. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00053-6
Akhtar, K., Alam, S., Abbas, S. A., Siddiqui, S. S., & Moin, S. (2020) · IP Indian Journal of Neurosciences · doi:10.18231/j.ijn.2020.020
Neuropathic Pain Syndrome: Diabetic and Other Neuropathies
Sawada, A., & Yamakage, M. (2020) · Springer eBooks · doi:10.1007/978-981-15-2933-7_14
Bertollo, N., & Calvagno, M. (2014) · Revista de la Sociedad Argentina de Diabetes · doi:10.47196/diab.v48i2.209
Kronik Hemodiyalizli Olguların Ayaklarında Periferik Nöropatinin Araştırılması
ÖZDEMİR, Ü., Keser, S., Bayraktaroğlu, T., & Borazan, A. (2020) · Turkish Journal of Diabetes and Obesity · doi:10.25048/tudod.610223
“-Mak) 59,6±13,8 61 (29-85) 66,9±9,3 67 (48-88) 56,6 ±8,2 57 (38-7457) 0,760 0,240 0,122 Cinsiyet(K/E) 13/22 14/12 30/20 VKİ (kg/m2±SS) Med.”
InfluentialAmeen, P. J. M., Kathum, T. J., & Baker, H. (2011) · DOAJ (DOAJ: Directory of Open Access Journals)
Oleiwi, S. R. (2020) · Indian Journal of Forensic Medicine & Toxicology · doi:10.37506/ijfmt.v14i2.2919
Abolghasemi, J., Rad, M. M., Soheilipour, F., Baradaran, H. R., Rimaz, S., & Kargarian-Marvasti, S. (2020) · Research Square · doi:10.21203/rs.3.rs-110176/v1
Cutaneous immunity and predisposition to infections in diabetic foot population
Andrei, P. M., Tănăsescu, M. D., Mincă, A., Balcangiu‐Stroescu, A.-E., Bălan, D., Mihai, A. D., Limbău, A. M., & Tîrgoviște, C. I. (2020) · Romanian Medical Journal · doi:10.37897/rmj.2020.2.1
Neurological diseases, epidemiology, and public health
Kukull, W. A., Govender, K. N., & Bowen, J. D. (2021) · doi:10.1093/med/9780198816805.003.0068
(2001) · Diabetic Medicine · doi:10.1046/j.1464-5491.2001.00001-4.x
High Risk Foot Among Type-2 Diabetes Mellitus Patients in a Tertiary Care Hospital
Mohiuddin, M. A. K. (2022) · Annals of International medical and Dental Research · doi:10.53339/aimdr.2022.8.1.38
Tesfaye, S. H., & Wu, J. (2022) · doi:10.1093/med/9780198870197.003.0278
Self-citationDiabetes and the Nervous System
Vinik, A. I., CASELLINI, C. M., & Neumann, S. A. (2019) · Endocrinology · doi:10.1007/978-3-319-27316-7_10-3
Glycemic Targets and Prevention of Chronic Complications
Cernea, S., Cahn, A., & Raz, I. (2018) · Endocrinology · doi:10.1007/978-3-319-45015-5_14
(2006) · Wiley eBooks · doi:10.1002/9780470041000.cedt070
Diabetes and the Nervous System
Vinik, A. I., CASELLINI, C. M., & Neumann, S. A. (2018) · Endocrinology · doi:10.1007/978-3-319-27316-7_10-2
Tesfaye, S. H. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-791-0_3
Self-citationConway, B. N., & Peltier, A. (2013) · InTech eBooks · doi:10.5772/55372
Diabetic neuropathy in children and youth
Akıncı, G., Savelieff, M. G., Gallagher, G., Callaghan, B. C., & Feldman, E. L. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-820669-0.00002-5
Kong, M., & Horowitz, M. (2007) · Springer eBooks · doi:10.1007/978-88-470-0638-6_32 · Cited by 1
Introduction to diabetic neuropathies
Boulton, A. J. M., & Vileikytė, L. (2011) · doi:10.1007/978-1-908517-16-6_1
Dressings for the treatment of diabetic foot ulceration
Speak, K., & Thow, J. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006473
What is the Evidence that Changing Tobacco use Reduces the Incidence of Diabetic Complications?
Wingard, D. L., Barrett-Connor, E. L., & Wedick, N. M. (2010) · Wiley eBooks · doi:10.1002/9780470682807.ch8
Dressings for the treatment of diabetic foot ulceration
Speak, K., & Thow, J. C. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006473.pub2
Kunze, K. (1999) · Springer eBooks · doi:10.1007/978-3-662-10477-4_82
Tesfaye, S. H. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-168-8_4
Self-citationTesfaye, S. H. (2011) · doi:10.1093/med/9780199235292.003.1529
Self-citationBilous, F. R., & Donnelly, R. (2010) · Wiley eBooks · doi:10.1002/9781444391374.ch17
Spinal Cord Stimulation in the Treatment of Postherpetic Neuralgia
Golovac, S., & Raso, L. J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-1560-2_68
Neurological diseases, epidemiology, and public health
Kukull, W. A., & Bowen, J. M. (2015) · doi:10.1093/med/9780199661756.003.0210
Gharpure, M., Varma, N., Rao, G., Vekariya, S., & Mote, R. (2022) · Research Square · doi:10.21203/rs.3.rs-1734021/v1
Neuropathie diabétique : mise au point
Lopes, S. A., Fayolle, D., & Jornayvaz, F. R. (2022) · JMIG · doi:10.53738/revmed.2022.18.784.1106 · Cited by 2
A dohányzás szerepe a cukorbetegség és szövődményeinek kialakulásában
Körei, A. E., Putz, Z., Istenes, I., Tordai, D. Z., Hajdú, N., Békeffy, M. Z., Vági, O. E., & Kempler, P. (2022) · Diabetologia Hungarica · doi:10.24121/dh.2022.18
Diabetic Neuropathy and Rehabilitation Treatment
Ueno, H., Kakita, M., Amaya, F., & Mikami, Y. (2022) · リハビリテーション医学 : 日本リハビリテーション医学会誌 · doi:10.2490/jjrmc.59.1222
Navarro, X., & Kennedy, W. R. (2023) · Springer eBooks · doi:10.1007/978-3-031-20999-4_59
Dubey, N., Kumar, S., Farrukh, A., & Budholia, P. K. (2023) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2023.v16i10.48380
Insight on development and management of neuropathic pain
Kaur, M., & Rajput, P. (2023) · Pharmaspire · doi:10.56933/pharmaspire.2023.15127
Lozeron, P. (2024) · EMC - Neurologia · doi:10.1016/s1634-7072(24)48980-0
T, R. N. D. (2024) · International Journal of Science and Research (IJSR) · doi:10.21275/sr24228120542
Diabetic Dermopathy (Diabetic Shin Spots)
Nwabudike, L. C. (2024) · Springer eBooks · doi:10.1007/978-3-031-65300-1_6
Chinthamaduka, K., & Makwana, P. V. (2022) · International Journal of Science and Research (IJSR) · doi:10.21275/sr22508132036
Proporción de polineuropatía diabética y sus posibles factores asociados
Ruiz, M. Á., Cifuentes, M., Fuentes, M. A. B., Mora, J., Bohórquez-Ballén, M. C., & Silva, M. (2025) · Universitas Médica · doi:10.11144/javeriana.umed66.ppdp
Eilers, M. C., Fellmann, M., l’Allemand, D., Wurster, J., Meier, S., Lütschg, J., Gruener, M.-R., West, E., Muhitira, U., Oberhauser, S. S., et al. (2025) · medRxiv · doi:10.1101/2025.05.24.25328284
Sarathchandra, C., & Kulathunga, A. (2025) · Journal of Tropical Health · doi:10.4038/joth.v1i2.15
Montes, F. B., Carriel, F. A., Dias, J. C. R., Mattos, L. O., Barcellos, C. R. G., Filho, I. T., & Garcia, G. C. D. M. (2025) · Revista de Medicina · doi:10.11606/issn.1679-9836.v104i4e-231487
Jones, B., Pengelly, R. J., Borthwick, A., & Bowen, C. J. (2025) · Journal of Foot and Ankle Research · doi:10.1002/jfa2.70062
“…characteristics consisted of: Cross‐ sectional studies (13) [6, 38–48], cohort (9) [6, 38, 49–55], reviews (9) [8, 10, 56–62], epidemiology (6) [6, 38, 55, 56, 63, 64], case–control (3) [65–67], position statements (2) [68, 69], validation/other(2)[7,9],guidelines(1)[70]andspecialreports(1)[71].”
InfluentialMpandzou, G. A., Kaba, Y., Bandzouzi, P. E. G. S., Mounoundzi, E. J., Diatewa, J. E., Latou, D. H. M., Aloba, K. L. O., & Ossou-Nguıet, P. M. (2025) · World Journal of Neuroscience · doi:10.4236/wjns.2025.153017
Peters, K. E., Davis, T. M. E., Joubert, I. A., Mead, M. K., Bautista, A. P. R., & Davis, W. A. (2025) · Scientific Reports · doi:10.1038/s41598-025-24110-8
“Although considered largely irreversible, 7 there are several potentially modifiable major risk factors including poor glycemic control, dyslipidemia, smoking and hypertension 8 .”
Barry, M. (2013) · University of Brighton Repository (University of Brighton)
Lian, X., Qi, J., Yuan, M., Li, X., Wang, M., Li, G., Yang, T., & Zhong, J. (2023) · Figshare · doi:10.6084/m9.figshare.23827021
Lian, X., Qi, J., Yuan, M., Li, X., Wang, M., Li, G., Yang, T., & Zhong, J. (2023) · Figshare · doi:10.6084/m9.figshare.23827018
Lian, X., Qi, J., Yuan, M., Li, X., Wang, M., Li, G., Yang, T., & Zhong, J. (2023) · Figshare · doi:10.6084/m9.figshare.23827015
Lian, X., Qi, J., Yuan, M., Li, X., Wang, M., Li, G., Yang, T., & Zhong, J. (2023) · Figshare · doi:10.6084/m9.figshare.23827027
Lian, X., Qi, J., Yuan, M., Li, X., Wang, M., Li, G., Yang, T., & Zhong, J. (2023) · Figshare · doi:10.6084/m9.figshare.23827024
Yoshida, Y., Onishi, Y., Kubota, T., Takao, T., Tahara, T., Iwamoto, M., Kawazu, S., Iwamoto, Y., Noda, M., & Kasuga, M. (2026) · Diabetology International · doi:10.1007/s13340-026-00881-x
“Hypergly-cemia and prolonged duration of diabetes are widely recognized as the primary risk factors for the onset of diabetic neuropathy and retinopathy [22, 32, 34–38].”
Dago, P. K., Gouh, F. L., Gnahoré, P. H., Attiégoua, E., Anselme, N. Y., Bouadi, I., Hué, A., Kouassi, F., Yao, A., Danho, J., et al. (2026) · Open Journal of Endocrine and Metabolic Diseases · doi:10.4236/ojemd.2026.167015
Peripheral nerve complications from medications utilised for weight loss: a systematic review
O’Gorman, C., O’Gorman, M., & Warren, N. (2026) · Journal of Neurology · doi:10.1007/s00415-026-14048-w
Advanced glycation and type 1 diabetes
Nin, J. W. M. (2012) · Research Publications (Maastricht University) · doi:10.26481/dis.20120607jn
Metadata
- Authors
- Tesfaye, S., Stevens, L. K., Stephenson, J. M., Fuller, J. H., Plater, M., Ionescu-Tirgoviste, C., Nuber, A., Pozza, G., & Ward, J. D.
- Affiliations
- Royal Liverpool University Hospital (GB)
- University College London (GB)
- Royal Hallamshire Hospital (GB)
- München Klinik Schwabing (DE)
- IRCCS Ospedale San Raffaele (IT)
- Venue
- Diabetologia
- Published
- 1996-10-23
- Volume
- 39
- Issue
- 11
- Pages
- 1377-1384
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2049568996
- Cited by
- 695
- References
- 30
- Citations by year
- 2026: 7 · 2025: 20 · 2024: 17 · 2023: 30 · 2022: 27 · 2021: 34 · 2020: 32 · 2019: 30 · 2018: 35 · 2017: 23 · 2016: 27 · 2015: 36 · 2014: 41 · 2013: 36 · 2012: 27
- FWCI
- 7.52
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Pfizer
- Novo Nordisk
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetic Foot Ulcer Assessment and Management
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- diabetic peripheral neuropathy, prevalence, type 1 diabetes, glycemic control, risk factors, diabetes duration, diabetic retinopathy, smoking, HDL cholesterol, cardiovascular disease, diastolic blood pressure, ketoacidosis, fasting triglycerides, microalbuminuria, autonomic dysfunction, erectile dysfunction, alcohol consumption
- MeSH terms
- Adolescent, Adult, Blood Pressure, Body Constitution, Cardiovascular Diseases, Diabetes Mellitus, Type 1, Diabetic Neuropathies, Diabetic Retinopathy, Europe, Female, Humans, Hypoglycemia, Lipids, Male, Middle Aged, Peripheral Nervous System Diseases, Regression Analysis, Risk Factors, Smoking, Body Mass Index, Prevalence, Diabetic Ketoacidosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.